Telomir Pharmaceuticals, Inc. TELO

1.23 0.02 1.65% as of 25 Sep

Follow TELO

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(1,885.50%)	(384.26%)	(317.65%)	(301.57%)	+8 more TTM periods Free account
ROA Full definition →	(1,678.31%)	(293.73%)	(240.34%)	(265.05%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(1,032.88%)	(185.89%)	(176.09%)	(160.34%)
Free Cash Flow per Share Full definition →	(0.08)	(0.13)	(0.12)	(0.10)
Free Cash Flow Full definition →	(4.91)	(4.60)	(3.69)	(3.09)
Piotroski F-Score Full definition →	2.00	3.00	3.00	3.00
Other line items
Cash ROIC Full definition →	(47.53%)	(42.87%)	(27.94%)	(21.61%)
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →	0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →	0.09	0.50	0.35	0.28
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(0.08)	(0.13)	(0.12)	(0.10)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Net Profit Margin Full definition →	0.00%	0.00%	0.00%	0.00%

Columns are period end dates

Powerpack